Goralatide / Thymosin Beta-4 (1-4)
The Book of Peptides is not a clinic and not your doctor. We do not sell, prescribe, recommend, or personalize any compound, and no grade or ranking here is an endorsement. In the United States, most of these compounds are not FDA-approved and are sold for laboratory research only; a few are prescription drugs, and some are controlled substances or banned in sport. Possessing or administering an unapproved compound outside an authorized setting may be unlawful. Nothing here is a recommendation to buy, possess, or self-administer anything. Consult a licensed physician before any decision involving peptide use.
Not reconstituted — vialsdelivery, so there's no vial to draw from.
A naturally occurring N-terminal tetrapeptide of Thymosin Beta-4, sold on its own as an anti-fibrotic distinct from full TB-500. It has a substantial preclinical literature showing anti-fibrotic and pro-angiogenic effects across heart, lung, kidney, and liver models, largely via TGF-beta/Smad inhibition and reduced fibroblast-to-myofibroblast conversion. That said, essentially all of this evidence is from animal and cell studies – there is no controlled human data supporting the recovery and anti-scarring uses it is marketed for.
